Cleared Traditional

K113500 - CANADY VIEIRA HYBRID PLASMA SCALPEL

K113500 is an FDA 510(k) clearance for CANADY VIEIRA HYBRID PLASMA SCALPEL, manufactured by Us Medical Innovations, LLC. The device is a Class 2 General & Plastic Surgery device with product code GEI cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K113500 · Us Medical Innovations, LLC · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
14d
Days
Class 2
Risk

K113500 is an FDA 510(k) clearance for the CANADY VIEIRA HYBRID PLASMA SCALPEL. Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Us Medical Innovations, LLC (Lakeland, US). The FDA issued a Cleared decision on December 9, 2011 after a review of 14 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Us Medical Innovations, LLC devices

FDA 510(k) Submission Details - K113500

510(k) Number K113500 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 25, 2011
Decision Date December 09, 2011
Days to Decision 14 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 115d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

GEI Device Classification - Class 2, Special Controls

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Tuv Sud America, Inc.
NORBERT STUIBER

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 2002
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K113500.
HALO60 ABLATION CATHETER
K112454 · Barrx Medical, Inc. · Jan 2012
ENDOSCOPIC MONOPOLAR INSTRUMENTS AND ACCESSORIES
K102921 · Bema-GmbH & Co. KG · Dec 2011
UNMIAX LAPAROSCOPIC INSTRUMENT
K103508 · Unimax Medical Systems, Inc. · Dec 2011
DISPOSABLE SPETZLER-MALIS DUAL IRRIGATING BIPOLAR FORCEPS
K110924 · Synergetics, Inc. · Dec 2011
AQUAMANTYS SBS 5.0 SHEATED BIOPOLAR SEALER
K111732 · Salient Surgical Technologies, Inc. · Dec 2011
APOLLO
K111026 · Pollogen, Ltd. · Nov 2011

FDA 510(k) Resources - General & Plastic Surgery

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.